CHARACTERISTICS OF THE PROBIOTIC BACTERIA STRAINS CONTAINED IN LIVING FOOD PROBIOTICS IN LIQUID FORM
Live and active strains of probiotic bacteria that are in our products belong to the genus Lactobacillus, Bifidobacterium and Streptococcus. These bacteria occur naturally in the human gut microbiota. They cause multidirectional, beneficial effects (both local and systemic) for the functioning of the body. This has been confirmed by numerous studies.
It should be remembered that each probiotic strain should be marked with both the generic name, species name and letter-numeral designation. The probiotic properties of microorganisms are strain-dependent, i.e. characteristic to one specific strain.
The functionality of the probiotic bacteria strains has been confirmed by both in vitro and in vivo tests. The characteristics of the strains presented in the table are based on numerous research reports.
Below is a list of probiotic bacteria strains contained in our products. The probiotic bacteria in our products appear in appropriately selected sets.
STRAINS OF PROBIOTIC BACTERIA
| Strains of probiotic bacteria | Effects | |
|---|---|---|
| Bacteria of the genus Lactobacillus | ||
| Lactobacillus acidophilus LA 1 | Contributes to the maintenance of the proper condition of the digestive tract in patients with ulcerative colitis. | |
| Lactobacillus acidophilus LA 02 | It relieves of IBS*symptoms and regulates the absorption processes from the intestinal lumen. It shows antagonistic activity against pathogenic bacteria of the species Helicobacter pylori, Salmonella enteritidis and Escherichia coli. It affects the proper functioning of the cardiovascular system. It has an effect related to the creation and maintenance of vaginal biofilm - it makes it difficult to persist the infection caused by Candida. It reduces inflammation of the genital tract. |
|
| Lactobacillus casei 101/37 | It has immunomodulatory properties and helps to relief of IBS* symptoms. | |
| Lactobacillus casei LC 03 | It has the ability to maintain long-term homeostasis of the body and has immunomodulatory properties. | |
| Lactobacillus delbrueckii ssp. bulgaricus LB 2 | It has the ability to maintain remission in patients with ulcerative colitis, and helps to relief of IBS* symptoms. | |
| Lactobacillus fermentum LF2 | It has the ability to produce high concentrations of exopolysaccharide, which contributes to lowering blood cholesterol. It has anti-cancer, anti-ulcer and immunomodulating properties. | |
| Lactobacillus helveticus ATB-LHS906 | It has the ability to stimulate the immune response. It modulates the intestinal microbiota, has antimicrobial properties against pathogens. | |
| Lactobacillus jensenii KS121.1 | It supports the natural composition of the vaginal microflora of healthy women, and prevents sexually transmitted diseases. It reduces the viability of vaginal pathogens Gardnerella vaginalis and Prevotella bivia by producing hydrogen peroxide and compound (s) resistant to the proteolytic enzyme. It has anti-inflammatory properties, produces biosurfactants that have the ability to counteract infections related to the genitourinary system, gastrointestinal tract and skin. It inhibits the growth, viability and cell adhesion properties to the uropathogenic strain of Escherichia coli (Afa / Dr DAEC) involved in recurrent cystitis. | |
| Lactobacillus paracasei LPC 00 | It helps to restore the microbiological balance of the intestines (elimination of dysbiosis) and is characterized by the production of riboflavin (vitamin B2). | |
| Lactobacillus pentosus LPS 01 | It is characterized by antimicrobial activity against fungi and strains of bacteria of the species Escherichia coli. It has strong anti-inflammatory properties. | |
| Lactobacillus plantarum ATB-LPM907 (LMG 26655) | It modulates the intestinal microbiota, has antimicrobial properties against pathogens. It has immunomodulatory properties. | |
| Lactobacillus plantarum LP 01 | It has properties relief of IBS* symptoms, it allows to increase the frequency of bowel movements in children with functional constipation. It has strong antimicrobial properties against strains of bacteria of the species Escherichia coli. | |
| Lactobacillus plantarum LP 02 | It is characterized by antimicrobial activity against strains of the species Escherichia coli. It contributes to the reduction of the incidence of respiratory diseases. | |
| Lactobacillus plantarum LP 09 | It has a beneficial effect in the treatment of hypercholesterolaemia and has an inhibitory effect against pathogenic bacteria of the species Listeria monocytogenes. | |
| Lactobacillus reuteri LRE 02 | It shows antioxidant activity and is characterized by the production of riboflavin. | |
| Lactobacillus rhamnosus ATB-LRS905 | It produces β-galactosidases, enzymes that support the digestion of lactose in people intolerant to this disaccharide. It stimulates a proper immune response, and due to the ability to produce hydrogen peroxide, it has a bactericidal effect. | |
| Lactobacillus rhamnosus GG | It has a positive effect on the immune system (supports immunity) and the digestive system, has antiallergic properties, promotes the effective treatment of IBD**, prevents and alleviates diarrhea associated with antibiotic therapy, reduces the duration of diarrhea of various etiologies, positively affects the side effects associated with Helicobacter pylori therapy , promotes the proper development of infants, and also shortens the regeneration time of the body after training and reduces gastrointestinal complaints in physically active people, and many other functional properties described in numerous scientific publications. | |
| Lactobacillus rhamnosus LR 04 | It helps to reduce the incidence and severity of respiratory diseases. It has strong antimicrobial activity against strains of the species Escherichia coli. It is highly effective in the treatment of chronic diarrhea in the elderly. | |
| Lactobacillus rhamnosus LR 05 | It has anti-inflammatory and immunomodulating properties, and is used to treat allergies. | |
| Lactobacillus rhamnosus LR 06 | It has antimicrobial activity against pathogenic bacteria (including strains of the species Escherichia coli) and has antifungal activity. It reduces the number of sulfate-reducing bacteria, favorably affecting the health of people with halitosis. | |
| Bacteria of the genus Bifidobacterium | ||
| Bifidobacterium breve BL 10 | It has a positive effect on the maintenance of remission in patients with ulcerative colitis, contributes to the relief of IBS* symptoms. | |
| Bifidobacterium breve Bbr 8 | It has a positive effect in maintaining remission in patients with ulcerative colitis and contributes to the relief of IBS* symptoms. | |
| Bifidobacterium breve ATB-BBE804 (LMG 13208) | It has the ability to biotransform linoleic acid into conjugated linoleic acid. | |
| Bifidobacterium breve BR 03 | It promotes regeneration processes after training, alleviates decrease of performance and reduces muscle tension after strength exercises. It relieves the symptoms of asthma, celiac disease and atopic dermatitis. It has anti-inflammatory properties and antimicrobial activity against strains of bacteria of the Escherichia coli species. It helps to increase the number of bowel movements and restore the microbial balance during IBS* treatment. | |
| Bifidobacterium bifidum BB 01 | It neutralizes the dysbiosis of the intestinal microbiota. It has strong anti-inflammatory properties. | |
| Bifidobacterium longum BL 03 | It has strong anti-inflammatory properties. It contributes to the increased frequency of bowel movements in children with functional constipation. | |
| Bifidobacterium longum W11 | It contributes to the increase in the frequency of bowel movements in patients with constipation, helps to reduce abdominal pain, reduces flatulence and discomfort associated with antibiotic therapy. Supports the treatment of hepatic encephalopathy. | |
| Bifidobacterium longum ATB-BLM802 | It produces β-galactosidases, enzymes that help digest lactose in people who are intolerant to this disaccharide. | |
| Bifidobacterium animalis ssp. lactis Bi 1 | It has a positive effect in maintaining remission in patients with ulcerative enteritis and contributes to the relief of IBS* symptoms. | |
| Bifidobacterium animalis ssp. lactis BS 01 | It stimulates the body's immune response. Reduce the incidence of respiratory diseases. It prevents the development of potentially pathogenic bacteria as well as fungi and molds - it competes with pathogens for the place of growth and nutrients, and also produces beneficial metabolites. It helps to restore the intestinal microbiological balance, reduces gastrointestinal discomfort. It contributes to an increase in the frequency of bowel movements in children with functional constipation, and to the restoration and maintenance of physiological intestinal transport (intestinal motility) in people with impaired intestinal peristalsis. | |
| Bacteria of the genus Streptococcus | ||
| Streptococcus thermophilus Z 57 | Contributes to the relief of IBS* symptoms. | |
| Streptococcus thermophilus 9 Y | It is active in modulating the immune response, contributes to the maintenance of remission in patients with colitis and the relief of IBS* symptoms. | |
| Streptococcusthermophilus FP 4 | It alleviates the decrease of performance and muscle tension after muscle-damaging exercise (strength training). Supports recovery after physical activity. It shows high anti-inflammatory activity. It has the potential to treat infections caused by Candida yeast and some bacterial strains, due to the production of biosurfactants with anti-adhesive and antimicrobial properties. | |
| * IBS - irritable bowel syndrome | ** IBD - inflammatory bowel disease |
